Andy Molnar, CEO of the Digital Therapeutics Alliance, has been selected as an industry representative for the FDA's Digital Health Advisory Committee (DHAC).
The FDA established the DHAC to ensure safe and effective regulation of digital health offerings, including AI and machine learning, virtual reality, cybersecurity, patient-generated health data and wearable technologies.
The committee...
